Reach Us +1(631)596-0675
The Role Of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) In Colitis | 58057
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

The role of Granulocyte-macrophage colony stimulating factor (GM-CSF) in colitis

9th Euro Global Gastroenterology Conference

Maitham Khajah, and Donna-Marie McCafferty

Faculty of Pharmacy, Kuwait University, Kuwait University of Calgary, Canada

ScientificTracks Abstracts: J Gastrointest Dig Syst

DOI: 10.4172/2161-069X.C1.043

Background: GM-CSF is a well-established priming agent and exerts proliferative effects for hematopoietic cells. Recent evidence suggests a potent chemotactic property towards neutrophils in vitro. Aim: To examine the role of GM-CSF in neutrophil recruitment to the colon in vivo and its effect on modulating colitis severity using the 2, 4, 6-trinitrobenzene sulphonic acid (TNBS) model in mice. Methods: Colitis was induced by a single intra rectal injection of TNBS (4mg, 20% ethanol) at day 1. Animals were treated with a single i.p injection of neutralizing anti-GM-CSF antibody (100 μg/mouse) on day 1, or multiple injections on day 1,2,3, and 4, and sacrificed on day 5 post-induction of colitis. Control mice were injected with i.p saline (vehicle) plus TNBS. On another experimental setup, colitis was induced in GMCSFRβ-/- and compared to wild type (WT) mice. Results: enhanced GMCSF expression (at both gene and protein levels) was observed in colonic tissues at day 3 and 7 post colitis induction. A single injection of GM-CSF antibody did not modulate colitis severity, while multiple injections significantly reduced colonic MPO activity and colitis severity. In the GMCSFRβ-/- mice, colonic MPO activity was significantly reduced post colitis induction but no improvement in colitis severity was observed compared to WT mice. Conclusion: Anti-GM-CSF therapy significantly reduced neutrophil recruitment to the colon leading to reduced colitis severity.

Maitham Khajah has completed his B. Pharm degree from Faculty of Pharmacy, Kuwait University and obtained his Ph.D. degree from the University of Calgary, Canada. He is currently an Assistant Professor in Kuwait University, Faculty of Pharmacy, Department of Pharmacology & Therapeutics since January 2010. His research interest focuses on studying new targets for the treatment of inflammatory bowel disease. He published various abstracts and peer reviewed manuscripts in international journals. He co-supervised many students for the Molecular Biology Program. Since he joined Kuwait University, he got various grants as PI and Co-I. He was awarded the Best young researcher award by Kuwait University for the year 2013 – 2014.

Email: [email protected]